FDA.reportPublic FDA data

Application 212309

Type
ANDA
Sponsor
BE PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINEPOWDER;INTRAVENOUSEQ 150MG BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0781-3497FosaprepitantFosaprepitantSandoz Inc.ANDACurrent
0781-3497FosaprepitantFosaprepitantSandoz Inc.ANDACurrent
68001-517fosaprepitantfosaprepitantBluePoint LaboratoriesANDACurrent
68001-517fosaprepitantfosaprepitantBluePoint LaboratoriesANDACurrent
69097-830fosaprepitantfosaprepitantCipla USA Inc.ANDACurrent
69097-830fosaprepitantfosaprepitantCipla USA Inc.ANDACurrent
70860-782Fosaprepitantfosaprepitant dimeglumineAthenex Pharmaceutical Division, LLC.ANDACurrent
71288-418FOSAPREPITANTFOSAPREPITANTMeitheal Pharmaceuticals Inc.ANDACurrent
71288-418FOSAPREPITANTFOSAPREPITANTMeitheal Pharmaceuticals Inc.ANDACurrent
71288-418FOSAPREPITANTFOSAPREPITANTMeitheal Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
71839-104fosaprepitantfosaprepitantBE Pharmaceuticals Inc.ANDACurrent
72603-106FOSAPREPITANTFOSAPREPITANTNorthStar Rx LLCANDACurrent
72603-106FOSAPREPITANTFOSAPREPITANTNorthStar Rx LLCANDACurrent